PFM Health Sciences’s ICU Medical ICUI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q2
Sell
-122,703
Closed -$20.2M 88
2023
Q1
$20.2M Buy
+122,703
New +$21.1M 0.89% 44
2022
Q4
Sell
-160,250
Closed -$24.1M 91
2022
Q3
$24.1M Sell
160,250
-81,935
-34% -$13.6M 0.87% 50
2022
Q2
$39.8M Buy
242,185
+21,598
+10% +$4.16M 1.52% 25
2022
Q1
$49.1M Hold
220,587
1.84% 19
2021
Q4
$52.4M Hold
220,587
1.78% 21
2021
Q3
$51.5M Sell
220,587
-35,121
-14% -$7.37M 1.51% 27
2021
Q2
$52.6M Sell
255,708
-34,953
-12% -$7.19M 1.65% 21
2021
Q1
$59.7M Buy
290,661
+22,844
+9% +$4.82M 1.82% 18
2020
Q4
$57.4M Sell
267,817
-35,182
-12% -$6.82M 2.02% 12
2020
Q3
$55.4M Buy
302,999
+77,448
+34% +$14.6M 2.56% 7
2020
Q2
$41.6M Buy
225,551
+23,212
+11% +$4.61M 2.16% 14
2020
Q1
$40.8M Buy
202,339
+36,674
+22% +$7.06M 3.35% 8
2019
Q4
$31M Buy
+165,665
New +$28.5M 1.48% 26
2019
Q3
Sell
-386,592
Closed -$97.4M 85
2019
Q2
$97.4M Buy
386,592
+11,732
+3% +$2.72M 1.85% 13
2019
Q1
$89.7M Buy
374,860
+199,102
+113% +$47.7M 1.98% 14
2018
Q4
$40.4M Buy
+175,758
New +$43.3M 1.07% 38

Other funds holding ICUI

PFM Health Sciences's ICUI Position: Q2 2023 in Review

PFM Health Sciences sold out of ICU Medical (ICUI) in Q2 2023, closing a stake of 122,703 shares — an estimated $20.2M sold.

PFM Health Sciences first reported a position in ICUI in Q4 2018 and held it in 16 quarters. The position peaked at $97.4M in Q2 2019. 231 funds tracked by Wall St. Rank hold ICUI as of Q2 2023.

  • PFM Health Sciences reported no remaining ICU Medical position as of Q2 2023 after selling out during the quarter.
  • PFM Health Sciences sold 122,703 ICU Medical shares in Q2 2023, an estimated $20.2M.
  • PFM Health Sciences first reported a position in ICU Medical in Q4 2018 and held it in 16 quarters.
  • PFM Health Sciences's ICU Medical position peaked at $97.4M in Q2 2019.
  • 231 funds tracked by Wall St. Rank held ICU Medical as of Q2 2023.

Based on PFM Health Sciences's 13F filing for Q2 2023, filed 14 Aug 2023.